Deciphera Pharmaceuticals Competitors and Similar CompaniesClear all

Deciphera Pharmaceuticals's competitors and similar companies include Exelixis, Celldex Therapeutics, Bristol Myers Squibb, Blueprint Medicines, Arog Pharmaceuticals and Allakos.
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
Exelixis
Exelixis
Exelixis a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer.
Celldex Therapeutics
Celldex Therapeutics
Celldex Therapeutics (formerly known as Avant Immunotherapeutics) is developing targeted therapeutics to address devastating diseases.
Bristol Myers Squibb
Bristol Myers Squibb
Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products.
Blueprint Medicines
Blueprint Medicines
Blueprint Medicines is a precision therapy company that invents medicines for people with cancer and blood disorders.
Arog Pharmaceuticals
Arog Pharmaceuticals
Arog Pharmaceuticals is a biopharmaceutical company dedicated to improving the lives of cancer patients by developing crenolanib in indications with high unmet need.
Allakos
Allakos
Allakos, a biopharmaceutical company, focuses on developing therapeutic antibodies targeting allergic, inflammatory, and proliferative diseases.
Founding Date
Founding Date
2003
Founding Date
1994
Founding Date
1983
Founding Date
1887
Founding Date
2011
Founding Date
2010
Founding Date
2012
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Waltham, US HQ
Lawrence, US
Locations
Alameda, US HQ
Locations
Hampton, US HQ
Fall River, US
Needham, US
New Haven, US
Locations
Princeton, US HQ
Mulgrave, AU
Pinewood, AU
Wien, AT
Braine L'alleud, BE
Bruxelles, BE
São Paulo, BR
see more
Locations
Cambridge, US HQ
Amsterdam, NL
Lugano, CH
Zug, CH
Locations
Plano, US HQ
Locations
Redwood City, US HQ
San Carlos, US
Employees
Employees
35037% increase
Employees
61727% increase
Employees
1327% increase
Employees
34,1001% decrease
Employees
6552% increase
Employees
1025% increase
Employees
967% increase
Valuation ($)
Valuation ($)
1.2 b
Valuation ($)
6.9 b
Valuation ($)
2.8 b
Valuation ($)
103.1 b
Valuation ($)
5.4 b
Valuation ($)
N/A
Valuation ($)
93.1 m
Twitter followers
Twitter followers
783
Twitter followers
5.8 k
Twitter followers
N/A
Twitter followers
156.9 k
Twitter followers
2.8 k
Twitter followers
N/A
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
16
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
1.5
Average likes per tweet (last 30 days)
1.9
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
6.4
Average likes per tweet (last 30 days)
3.7
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
50%
Percentage of tweets with engagement (last 30 days)
75%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
93.75%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A

Financial

Revenue (est.)
Revenue (est.)
$163.4m (FY, 2023)
Revenue (est.)
$1.8b (FY, 2023)
Revenue (est.)
$6.9m (FY, 2023)
Revenue (est.)
$45b (FY, 2023)
Revenue (est.)
$249.4m (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
$3.7m (FY, 2023)
Cost of goods
$72.5m (FY, 2023)
Cost of goods
$300k (FY, 2023)
Cost of goods
$10.7b (FY, 2023)
Cost of goods
$8.5m (FY, 2023)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$159.6m (FY, 2023)
Gross profit
$1.8b (FY, 2023)
Gross profit
$6.6m (FY, 2023)
Gross profit
$34.3b (FY, 2023)
Gross profit
$240.8m (FY, 2023)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($194.9m) (FY, 2023)
Net income
$207.8m (FY, 2023)
Net income
($141.4m) (FY, 2023)
Net income
$8b (FY, 2023)
Net income
($507m) (FY, 2023)
Net income
($11.6m) (FY, 2017)
Net income
($185.7m) (FY, 2023)

Funding

Total funding raised
Total funding raised
$ 714m
Total funding raised
N/A
Total funding raised
$ 2m
Total funding raised
$ 15.5m
Total funding raised
$ 1.7b
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Exelixis
HQ
Alameda, US
Employees
617↑ 27% increase

Exelixis a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer.

View company
Celldex Therapeutics
HQ
Hampton, US
Employees
132↑ 7% increase

Celldex Therapeutics (formerly known as Avant Immunotherapeutics) is developing targeted therapeutics to address devastating diseases.

View company
Bristol Myers Squibb
HQ
Princeton, US
Employees
34,100↓ 1% decrease

Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products.

View company
Blueprint Medicines
HQ
Cambridge, US
Employees
655↑ 2% increase

Blueprint Medicines is a precision therapy company that invents medicines for people with cancer and blood disorders.

View company